Renaissance Technologies LLC 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 10:53 am Purchase | 2023-12-29 | 13G | Vanda Pharmaceuticals Inc. VNDA | Renaissance Technologies LLC | 3,681,125 6.400% | 791,700 (+27.40%) | Filing |
| 2023-02-13 11:33 am Sale | 2022-12-30 | 13G | Vanda Pharmaceuticals Inc. VNDA | Renaissance Technologies LLC | 2,889,425 5.090% | -322,789 (-10.05%) | Filing |
| 2022-02-11 3:57 pm Sale | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Renaissance Technologies LLC | 3,212,214 5.770% | -778,189 (-19.50%) | Filing |
| 2021-02-11 2:34 pm Purchase | 2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Renaissance Technologies LLC | 3,990,403 7.300% | 537,291 (+15.56%) | Filing |